Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: A prospective cohort study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Zhang, Tao ^a   Zhang, Yongyuan ^b   Zhang, Chengqi ^c   Tang, Fang ^c   Li, Hongkai ^a   Zhang, Qian ^a   Lin, Haiyan ^a   Wu, Shuo ^a   Liu, Yanxun ^a   Xue, Fuzhong ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; NITROGEN; UREA;

ADULT; AGE; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; EXERCISE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMPLICATION; INCIDENCE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; URBAN POPULATION;

ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; URBAN POPULATION;

EID: 84900539261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096651     Document Type: Article

References (38)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med Overseas Ed 346: 1221-1231.
2. Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, et al. (2012) Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol 107: 1852-1858.
3. Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, et al. (2003) Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 98: 2064-2071. (Pubitemid 37185807)
4. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome - a new worldwide definition. Lancet 366: 1059-1062. (Pubitemid 41338752)
5. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (Baltimore, Md.) 37: 917-923. (Pubitemid 36397405)
6. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med Overseas Ed 363: 1341-1350.
7. Karnikowski M, Cordova C, Oliveira RJ, Karnikowski MG, Nobrega OT (2007) Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middleaged and older adults. Sao Paulo medical journal = Revista paulista de medicina 125: 333-337. (Pubitemid 351546553)
8. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850. (Pubitemid 33641605)
9. Smits MM, Ioannou GN, Boyko EJ, Utzschneider KM (2013) Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. J Gastroenterol Hepatol 28: 664-670.
10. Rector RS, Thyfault JP, Wei Y, Ibdah JA (2008) Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14: 185-192. (Pubitemid 351314297)
11. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK (2009) NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 104: 861-867.
12. Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y (2007) Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 22: 1086-1091. (Pubitemid 47019857)
13. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, et al. (2005) Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 20: 1825-1832. (Pubitemid 43961036)
14. Ryoo JH, Choi JM, Moon SY, Suh YJ, Shin JY, et al. (2013) The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study. Atherosclerosis 227: 398-403.
15. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, et al. (2007) The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102: 2708-2715. (Pubitemid 350179336)
16. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS (2009) Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 84: 84-91.
17. Fan JG, Farrell GC (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50: 204-210.
18. Fan JG, Zhu J, Li XJ, Chen L, Li L, et al. (2005) Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 43: 508-514. (Pubitemid 41111434)
19. Li Z, Xue J, Chen P, Chen L, Yan S, Liu L (2014) Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol 29: 42-51.
20. Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, et al. (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 9: 108-112. (Pubitemid 351566633)
21. Lu YH, Lu JM, Wang SY, Li CL, Liu LS, et al. (2006) [Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch]. Zhonghua yi xue za zhi 86: 386-389.
22. Schunk D (2008) A Markov chain Monte Carlo algorithm for multiple imputation in large surveys. AStA Advances in Statistical Analysis 92: 101-114.
23. Pagano C, Soardo G, Esposito W, Fallo F, Basan L, et al. (2005) Plasma adiponectin is decreased in nonalcoholic fatty liver disease. European journal of endocrinology/European Federation of Endocrine Societies 152: 113-118.
24. Salamone F, Bugianesi E (2010) Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. J Hepatol 53: 1146-1147.
25. Angelico F, Del BM, Conti R, Francioso S, Feole K, et al. (2005) Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 90: 1578-1582. (Pubitemid 40464021)
26. Tilg H, Moschen AR (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends in endocrinology and metabolism: TEM 19: 371-379.
27. Bhatia LS, Curzen NP, Calder PC, Byrne CD (2012) Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor. Eur Heart J 33: 1190-1200.
28. Bugianesi E, McCullough AJ, Marchesini G (2005) Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology (Baltimore, Md.) 42: 987-1000. (Pubitemid 43112663)
29. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (Baltimore, Md.) 37: 1202-1219. (Pubitemid 36538699)
30. Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24: 278-301. (Pubitemid 36724371)
31. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, et al. (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44: 1167-1174.
32. Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, et al. (2002) Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122: 274-280. (Pubitemid 34116980)
33. Grundy SM (2003) Inflammation, hypertension, and the metabolic syndrome. JAMA 290: 3000-3002.
34. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin. Hepatology (Baltimore, Md.) 40: 46-54. (Pubitemid 38868922)
35. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935. (Pubitemid 32472900)
36. Musso G, Gambino R, Bo S, Uberti B, Biroli G, et al. (2008) Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31: 562-568.
37. Athyros VG, Mikhailidis DP, Didangelos TP, Giouleme OI, Liberopoulos EN, et al. (2006) Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin 22: 873-883. (Pubitemid 43875555)
38. Gill HK, Wu GY (2006) Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer. World J Gastroenterol 12: 345-353. (Pubitemid 43329249)